Table 2.
ESE (n=11) | RSE (n=21) | p-value | |
---|---|---|---|
Male | 9 (47.4) | 10 (52.6) | 0.066 |
Age [yr, median (range)] | 35 (16–80) | 27 (16–81) | 0.611 |
Hypotension | 1 (9.1) | 17 (81.0) | 0.000 |
Acidosis | 5 (45.5) | 9 (42.9) | 0.298 |
Cardiac change | 2 (18.2) | 5 (23.8) | 0.544 |
Rhabdomyolysis | 5 (45.5) | 10 (47.6) | 0.500 |
Hepatic change | 2 (18.2) | 9 (42.9) | 0.158 |
Lipid change | 0 (0.0) | 6 (28.6) | 0.017 |
Death | 1 (9.1) | 8 (38.1) | 0.090 |
Arrhythmia | 1 (9.1) | 6 (28.6) | 0.212 |
Renal change | 3 (30.0) | 5 (23.8) | 0.575 |
Previous epilepsy | 6 (54.5) | 4 (19.0) | 0.050 |
Number of AED, median (range) | 4 (1–7) | 5 (1–8) | 0.628 |
AED; antiepileptic drug, numbers in the parentheses are percentile or range.